Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

Nowadays; intravitreal anti-vascular endothelial growth factor (VEGF) drugs are considered the first-line therapeutic strategy for treating macular exudative diseases; including wet age-related macular degeneration (w-AMD) and diabetic macular edema (DME). Despite the important clinical achievements...

Full description

Bibliographic Details
Main Authors: Lorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò, Marion R. Munk
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceutics
Subjects:
faricimab
anti-VEGF drugs
intravitreal injections
ang/tie
ang2
angiogenesis
Online Access:https://www.mdpi.com/1999-4923/15/5/1413

Internet

https://www.mdpi.com/1999-4923/15/5/1413

Similar Items